Developed by Regeneron Pharmaceuticals, an experimental cholesterol-lowering drug has proven itself effective in reducing the risk of heart attacks and strokes in a clinical trial. Researchers reported on Sunday that it actually halved the number of heart attacks and strokes of patients included in the critical trial. The study was retrospective and as such, is not yet conclusive, but it … [Read more...]
You are here: Home / Archives for alirocumab